Wells Fargo
XERS icon

Wells Fargo’s Xeris Biopharma Holdings XERS Stock Holding History

Wells Fargo’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-614,000
Closed -$401K – 7458
2020
Q4 		$401K Hold
614,000
– – ﹤0.01% 4677
2020
Q3 		$1.45M Buy
+614,000
New +$2.46M ﹤0.01% 3579

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo's XERS Position: Q1 2026 in Review

Wells Fargo reduced its Xeris Biopharma Holdings (XERS) stake by 66% in Q1 2026, selling an estimated $746K and leaving 58,307 shares worth $338K. The position accounts for ﹤0.01% of the portfolio, ranked #4366.

Wells Fargo first reported a position in XERS in Q3 2018 and has held it in 31 quarters since. The position peaked at $1.34M in Q4 2025. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

  • Wells Fargo held 58,307 shares of Xeris Biopharma Holdings worth $338K as of Q1 2026.
  • Wells Fargo sold 112,489 Xeris Biopharma Holdings shares in Q1 2026, an estimated $746K.
  • Xeris Biopharma Holdings made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #4366 holding.
  • Wells Fargo first reported a position in Xeris Biopharma Holdings in Q3 2018 and has held it in 31 quarters since.
  • Wells Fargo's Xeris Biopharma Holdings position peaked at $1.34M in Q4 2025.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.